Ilse Roodink
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ilse Roodink has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- William P. J. Leenders
Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
4 shared publications Jos Raats
ModiQuest B.V. and Department of Biomolecular Chemistry, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
2 shared publicationsKiek Verrijp
Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
2 shared publicationsCathy Maass
1 shared publicationGürsah Kats
1 shared publication- Jos Raats
ModiQuest B.V., Oss, The Netherlands
1 shared publication
Latest Publications
- 1 December 2010
- Published by Elsevier in Cancer Letters
- Vol. 299 (1) , 1-10
Targeted therapies of cancer: Angiogenesis inhibition seems not enough
- 1 December 2010
- Published by Elsevier in Cancer Letters
- Vol. 299 (1) , 1-10
Targeted therapies of cancer: Angiogenesis inhibition seems not enough
- 1 January 2010
- Published by Elsevier in Laboratory Investigation
- Vol. 90 (1) , 61-67
Isolation of targeting nanobodies against co-opted tumor vasculature
- 1 January 2010
- Published by Elsevier in Laboratory Investigation
- Vol. 90 (1) , 61-67
Isolation of targeting nanobodies against co-opted tumor vasculature
- Open Access
- 25 August 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 297
Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies
Plexin D1 is expressed on both tumor-associated endothelium and malignant cells in a number of clinical brain tumors. Recently we demonstrated that Plexin D1 expression is correlated with tumor invasion level and metastasis in a human melanoma progression series. The objective of this study was to examine whether Plexin D1 might be clinically useful as a pan-tumor vessel and pan-tumor cell target in solid tumors.
- 25 August 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 297
Open AccessPlexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies
Plexin D1 is expressed on both tumor-associated endothelium and malignant cells in a number of clinical brain tumors. Recently we demonstrated that Plexin D1 expression is correlated with tumor invasion level and metastasis in a human melanoma progression series. The objective of this study was to examine whether Plexin D1 might be clinically useful as a pan-tumor vessel and pan-tumor cell target in solid tumors.
- 1 December 2008
- Published by Elsevier in The American Journal of Pathology
- Vol. 173 (6) , 1873-1881
Semaphorin 3E Expression Correlates Inversely with Plexin D1 During Tumor Progression
- 1 December 2008
- Published by Elsevier in The American Journal of Pathology
- Vol. 173 (6) , 1873-1881
Semaphorin 3E Expression Correlates Inversely with Plexin D1 During Tumor Progression